GE HealthCare forecasts 2026 adjusted EPS $4.95-$5.05 while advancing SOFIE Biosciences acquisition

GE HealthCare Q3 2026 earnings insights: raised guidance, margin gains, PCS recovery, and SOFIE deal impact.

CryptoAlerta — análise de criptomoedas e mercado em tempo real